[HTML][HTML] LT-IIc, a bacterial type II heat-labile enterotoxin, induces specific lethality in triple negative breast cancer cells by modulation of autophagy and induction of …
P Masso-Welch, S Girald Berlingeri… - International Journal of …, 2018 - mdpi.com
Triple negative breast cancer (TNBC) remains a serious health problem with poor prognosis
and limited therapeutic options. To discover novel approaches to treat TNBC, we screened …
and limited therapeutic options. To discover novel approaches to treat TNBC, we screened …
LT-IIc, A Bacterial Type II Heat-Labile Enterotoxin, Induces Specific Lethality in Triple Negative Breast Cancer Cells by Modulation of Autophagy and Induction of …
P Masso-Welch, ND King-Lyons, L Mandell… - … Journal of Molecular …, 2018 - europepmc.org
Triple negative breast cancer (TNBC) remains a serious health problem with poor prognosis
and limited therapeutic options. To discover novel approaches to treat TNBC, we screened …
and limited therapeutic options. To discover novel approaches to treat TNBC, we screened …
LT-IIc, a bacterial type II heat-labile enterotoxin, induces specific lethality in triple negative breast cancer cells by modulaton of autophagy and induction of apoptosis …
PA Masso-Welch, SG Berlingeri, ND King-Lyons… - Cancer Research, 2019 - AACR
Despite the recent advances in breast cancer treatment, triple negative breast cancer
(TNBC) remains a serious health problem with limited treatment options. Poor prognosis is …
(TNBC) remains a serious health problem with limited treatment options. Poor prognosis is …
LT-IIc, A Bacterial Type II Heat-Labile Enterotoxin, Induces Specific Lethality in Triple Negative Breast Cancer Cells by Modulation of Autophagy and Induction of …
P Masso-Welch, SG Berlingeri, ND King-Lyons… - 2018 - agris.fao.org
Triple negative breast cancer (TNBC) remains a serious health problem with poor prognosis
and limited therapeutic options. To discover novel approaches to treat TNBC, we screened …
and limited therapeutic options. To discover novel approaches to treat TNBC, we screened …
LT-IIc, A Bacterial Type II Heat-Labile Enterotoxin, Induces Specific Lethality in Triple Negative Breast Cancer Cells by Modulation of Autophagy and Induction of …
P Masso-Welch, SG Berlingeri… - International …, 2018 - pubmed.ncbi.nlm.nih.gov
Triple negative breast cancer (TNBC) remains a serious health problem with poor prognosis
and limited therapeutic options. To discover novel approaches to treat TNBC, we screened …
and limited therapeutic options. To discover novel approaches to treat TNBC, we screened …
LT-IIc, A Bacterial Type II Heat-Labile Enterotoxin, Induces Specific Lethality in Triple Negative Breast Cancer Cells by Modulation of Autophagy and Induction of …
P Masso-Welch, S Girald Berlingeri… - International …, 2019 - search.ebscohost.com
Triple negative breast cancer (TNBC) remains a serious health problem with poor prognosis
and limited therapeutic options. To discover novel approaches to treat TNBC, we screened …
and limited therapeutic options. To discover novel approaches to treat TNBC, we screened …
LT-IIc, A Bacterial Type II Heat-Labile Enterotoxin, Induces Specific Lethality in Triple Negative Breast Cancer Cells by Modulation of Autophagy and Induction of …
P Masso-Welch, SG Berlingeri… - International …, 2019 - search.proquest.com
Introduction Triple-negative breast cancer (TNBC) is characterized by the lack of detectible
expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal …
expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal …
[HTML][HTML] LT-IIc, A Bacterial Type II Heat-Labile Enterotoxin, Induces Specific Lethality in Triple Negative Breast Cancer Cells by Modulation of Autophagy and Induction …
P Masso-Welch, SG Berlingeri… - … Journal of Molecular …, 2019 - ncbi.nlm.nih.gov
Triple negative breast cancer (TNBC) remains a serious health problem with poor prognosis
and limited therapeutic options. To discover novel approaches to treat TNBC, we screened …
and limited therapeutic options. To discover novel approaches to treat TNBC, we screened …